EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Triple antimicrobial combinations with potent synergistic activity against M. abscessus

Yanqin Huang, Lucius Chiaraviglio, Ibidunni Bode-Sojobi, James E Kirby iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01828-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Yanqin Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Mycobacterium abscessus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Massachusetts Life Sciences Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synergy of antimicrobial combinations was tested against contemporary Mycobacteroides abscessus isolates using 2D and 3D checkerboard assays. Triple combinations of omadacycline-azithromycin-clofazimine, tigecycline-azithromycin-clofazimine, omadacycline-azithromycin-linezolid, and omadacycline-azithromycin-contezolid demonstrated synergy (fractional inhibitory concentration index ≤ 0.5) against 33%, 31%, 62%, and 66% of isolates, respectively. Notably, in all triple combinations, macrolide-resistant M. abscessus subsp. abscessus and M. abscessus subsp. bolletii isolates were fully sensitized to azithromycin at the FIC index, as were isolates with elevated clofazimine MICs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsMycobacterium abscessusMicrobial Sensitivity TestsDrug SynergismTigecyclineAzithromycinLinezolidClofazimineTetracyclinesHumansDrug Combinations

Stichwörter der Autor:innen

Mycobacteroides abscessusazithromycinclofaziminecontezolidlinezolidmacrolidenon-tuberculous mycobacteriumomadacyclinesynergytherapeutics checkerboardtigecycline

Substanzen

TigecyclineAzithromycinAnti-Bacterial AgentsLinezolidClofazimineomadacyclineTetracyclinesDrug Combinations

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

ORCID-Profile: James E Kirby

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Massachusetts Life Sciences Center
  • Academy of Clinical Laboratory Physicians and Scientists

Zitieren

APA

Huang, Y., Chiaraviglio, L., Bode-Sojobi, I., & Kirby, J. E. (2025). Triple antimicrobial combinations with potent synergistic activity against M. abscessus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01828-24

Vancouver

Huang Y, Chiaraviglio L, Bode-Sojobi I, Kirby JE. Triple antimicrobial combinations with potent synergistic activity against M. abscessus. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01828-24

BibTeX
@article{Huang2025,
  author = {Huang, Yanqin and Chiaraviglio, Lucius and Bode-Sojobi, Ibidunni and Kirby, James E},
  title = {Triple antimicrobial combinations with potent synergistic activity against M. abscessus},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01828-24}
}
Kostenlos starten →